We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BPCR market cap is 1.14B. The company's latest EPS is USD 0.0833 and P/E is 10.56.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 150.91M | 110.02M | 103.88M | 218.17M | 135.74M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 122.33M | 89.14M | 84.96M | 182.31M | 108.45M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.43B | 1.39B | 1.37B | 1.36B | 1.36B |
| Total Liabilities | 25.24M | 9.39M | 6.9M | 26.56M | 15.87M |
| Total Equity | 1.4B | 1.38B | 1.36B | 1.34B | 1.34B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 131.52M | 58.07M | 96.44M | 184.28M | 123.18M |
| Investing | -100.3M | -47.47M | -94.82M | 48.19M | -1.66M |
| Financing | -98.15M | -113.96M | -100.16M | -206.62M | -106.99M |
| Market Cap | 1.14B |
| Price to Earnings Ratio | 10.56 |
| Price to Sales Ratio | 8.45 |
| Price to Cash Ratio | 8.49 |
| Price to Book Ratio | 0.85 |
| Dividend Yield | 7.97% |
| Shares Outstanding | 1.3B |
| Average Volume (1 week) | 2.17M |
| Average Volume (1 Month) | 2.08M |
| 52 Week Change | -7.19% |
| 52 Week High | 0.966 |
| 52 Week Low | 0.81 |
| Spread (Intraday) | 0 (0.23%) |
| Company Name | Biopharma Credit Plc |
| Address |
link company matters limited london, ontario EC2V 7NQ |
| Website | https:// |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
